Screener
Enliven Therapeutics ELVN Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Enliven Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211982
FAQ
- What is Enliven Therapeutics's return on invested capital?
- Enliven Therapeutics (ELVN) reported return on invested capital of -45.5% in Q1 2026.
- How has Enliven Therapeutics's return on invested capital changed year-over-year?
- Enliven Therapeutics's return on invested capital increased by 26.5% year-over-year, from -61.9% to -45.5%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Enliven Therapeutics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude